Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event
reported): September 16, 2025(July 1, 2025)

Pelthos Therapeutics Inc.

(Exact name of registrant as specified in its charter)</div>

| Nevada                       |     | 001-41964        |     | 86-3335449         |
| (State or other jurisdiction 
 of incorporation)            |     | -Commission File 
 Number           |     | -IRS Employer      
 Identification No. |

| 4020                                        
 Stirrup Creek Drive, Suite 110              
 Durham,                                     
 NC                                          |     | 27703 |
| (Address                                    
 of registrant’s principal executive office) |     |  -Zip 
  code |

<div align='center'>Registrant’s telephone number, including area code: (919) 908-2400

(Former name or former address, if changed since last report.)</div>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| ☐ | Written communications pursuant to Rule 425                
 under the Securities Act (17 CFR 230.425)                  |
| ☐ | Soliciting material pursuant to Rule 14a-12                
 under the Exchange Act (17 CFR 240.14a-12)                 |
| ☐ | Pre-commencement communications pursuant to                
 Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to                
 Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                              
 of each class                      |     | Trading   
 Symbol(s) |     | Name                                 
 of each exchange on which registered |
| Common                             
 Stock, par value $0.0001 per share |     | PTHS      |     | The                                  
 NYSE American LLC                    |

Indicate by check mark whether the